Stockscreener 앱 받기
19.06
1.06%
-0.21
전일 마감가:
$19.27
열려 있는:
$19.06
하루 거래량:
52,596
Relative Volume:
0.07
시가총액:
$2.14B
수익:
$418.33M
순이익/손실:
$-252.07M
주가수익비율:
-7.9417
EPS:
-2.4
순현금흐름:
$-238.84M
1주 성능:
-3.17%
1개월 성능:
+12.28%
6개월 성능:
-38.02%
1년 성능:
-46.91%
1일 변동 폭
$18.89
$19.22
1주일 범위
$17.10
$19.59
52주 변동 폭
$15.96
$44.34
Zai Lab Limited Adr Stock (ZLAB) Company Profile
명칭
Zai Lab Limited Adr
전화
862161632588
주소
899 HALEI ROAD, SHANGHAI
Compare ZLAB vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
19.10 | 2.16B | 418.33M | -252.07M | -238.84M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.45 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
770.22 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
733.95 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.94 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
294.07 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 재개 | Jefferies | Buy |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2025-03-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-12-14 | 개시 | Morgan Stanley | Overweight |
| 2023-08-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-01-21 | 개시 | Macquarie | Outperform |
| 2021-10-12 | 개시 | Bernstein | Mkt Perform |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-04-15 | 개시 | Guggenheim | Buy |
| 2019-07-12 | 개시 | BofA/Merrill | Buy |
| 2019-07-05 | 개시 | Macquarie | Outperform |
| 2019-01-29 | 개시 | Credit Suisse | Outperform |
| 2018-11-21 | 개시 | Jefferies | Buy |
| 2018-06-21 | 재개 | Leerink Partners | Outperform |
| 2018-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-10-16 | 개시 | JP Morgan | Neutral |
| 2017-10-16 | 개시 | Leerink Partners | Outperform |
모두보기
Zai Lab Limited Adr 주식(ZLAB)의 최신 뉴스
Zai Lab (NASDAQ:ZLAB) Shares Up 9.3%Should You Buy? - MarketBeat
[144] Zai Lab Ltd SEC Filing - Stock Titan
Affiliate sale: ZLAB (NASDAQ: ZLAB) files to sell 10,000 ADS - Stock Titan
Cantor Fitzgerald Lowers Zai Lab (NASDAQ:ZLAB) Price Target to $37.00 - Defense World
Zai Lab Q4 Earnings Call Highlights - Yahoo Finance
Zai Lab Limited 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ZLAB) 2026-02-27 - Seeking Alpha
Zai Lab (NasdaqGM:ZLAB) Loss Per Share Narrows To US$1.60 And Tests Bearish Narratives - Sahm
Zai Lab (NASDAQ:ZLAB) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Zai Lab Limited (ZLAB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Zai Lab Ltd SEC 10-K Report - TradingView
Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates - ChartMill
Zai Lab Q4 Earnings Summary & Key Takeaways - Sahm
An Overview of Zai Lab's Earnings - Sahm
Zai Lab (ZLAB) Expected to Announce Earnings on Thursday - MarketBeat
Zai Lab Stock Pops on U.S. FDA Progress: Is Wall Street Still Too Bearish? - AD HOC NEWS
Zai Lab (NASDAQ:ZLAB) Shares Gap Up – Here’s What Happened - Defense World
Qiming funds disclose 4.4% Zai Lab (ZLAB) stake in amended 13G/A - Stock Titan
Zai Lab (NASDAQ:ZLAB) Shares Gap UpHere's Why - MarketBeat
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives $51.59 Consensus Price Target from Analysts - Defense World
Constellation Software Inc. (OTCMKTS:CNSWF) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Analysts Set Kraken Robotics Inc. (CVE:PNG) PT at C$7.13 - Defense World
Brokerages Set Whirlpool Corporation (NYSE:WHR) Target Price at $85.43 - Defense World
Everus Construction Group, Inc. (NYSE:ECG) Receives $102.75 Average PT from Brokerages - Defense World
FY2026 Earnings Forecast for PACCAR Issued By Zacks Research - Defense World
Plexus Corp. (NASDAQ:PLXS) Receives $189.20 Average Target Price from Analysts - Defense World
Brokerages Set Adherex Technologies Inc. (NASDAQ:FENC) PT at $14.50 - Defense World
Brokerages Set Medical Properties Trust, Inc. (NYSE:MPW) Price Target at $6.17 - Defense World
Zai Lab Limited's (NASDAQ:ZLAB) Shift From Loss To Profit - Yahoo Finance
Zai Lab to Announce Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates on February 26, 2026 - Business Wire
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Wellington Group reports 4.3% Zai Lab (ZLAB) stake on amended 13G - Stock Titan
JPMorgan Chase & Co. Has Lowered Expectations for Zai Lab (NASDAQ:ZLAB) Stock Price - MarketBeat
$207B Market Shift: The Race for Fast Track Approval in Oncology - Benzinga
$207B Market Shift: The Race for Fast Track Approval in Oncology - Sahm
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Benzinga
Hilton Food Group (LON:HFG) Insider Purchases £198,900 in Stock - Defense World
Zai Lab (NASDAQ:ZLAB) Reaches New 1-Year Low – Time to Sell? - Defense World
Is UBS’s Global-Innovation Framing Rewriting Zai Lab’s (ZLAB) Long-Term Biopharma Platform Narrative? - Sahm
UBS Sees Zai Lab (ZLAB) as a Rising Global Biopharma Platform - Finviz
Zai Lab (NASDAQ:ZLAB) Sets New 12-Month LowHere's Why - MarketBeat
8 High Growth Chinese Stocks To Buy - Insider Monkey
Zai Lab Limited (ZLAB) Stock Analysis: Eyeing a 169% Potential Upside in the Biotech Arena - DirectorsTalk Interviews
Zai Lab (NASDAQ:ZLAB) Stock Rating Upgraded by Jefferies Financial Group - MarketBeat
Short Interest in AiRWA Inc. (NASDAQ:YYAI) Rises By 24.6% - Defense World
Short Interest in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Drops By 19.8% - MarketBeat
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Short Interest Update - Defense World
Assessing Zai Lab (NasdaqGM:ZLAB) Valuation After New AUGTYRO Approval And Pipeline Progress - Sahm
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Animalcare Group (LON:ANCR) Stock Passes Below 200-Day Moving Average – Here’s What Happened - Defense World
How Investors May Respond To Zai Lab (ZLAB) Winning Expanded China Approval For AUGTYRO Cancer Therapy - Sahm
Zai Lab Highlights Strategic Priorities and Global Pipeline Progress at 44th Annual J.P. Morgan Healthcare Conference - Chartmill
Zai Lab Limited Adr (ZLAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.50%
자본화:
|
볼륨(24시간):